Compass Pathways PLC
CMPS4.630USD
+0.290+6.68%
交易中 （美東）報價延遲15分鐘
433.30M總市值
虧損本益比TTM
關於 Compass Pathways PLC 公司
Compass Pathways plc 是一家總部位於英國的生物技術公司，致力於加速患者獲得心理健康領域循證創新的途徑。該公司致力於裸蓋菇素治療的開發，其中其研究性 COMP360 裸蓋菇素與心理支持 COMP360 裸蓋菇素治療相結合使用。COMP360 是其專有的裸蓋菇素配方，包括其藥物級多晶型裸蓋菇素，經過優化以提高穩定性和純度。該公司的初始重點是難治性抑鬱症 (TRD)，包括當前治療模式無法充分滿足的患者。該公司已啓動其 III 期計劃，評估其 COMP360 裸蓋菇素在 TRD 中的治療效果。此外，該公司正在開展 PTSD 和神經性厭食症的 II 期試驗。它還爲在嚴重未滿足需求的領域開展由研究人員發起的 COMP360 裸蓋菇素研究的研究機構提供支持。
公司簡介
公司代碼CMPS
公司名稱Compass Pathways PLC
上市日期Sep 18, 2020
CEOMr. Kabir Nath
員工數量166
證券類型Depository Receipt
年結日Sep 18
公司地址3Rd Floor, 1 Ashley Road
城市ALTRINCHAM
上市交易所NASDAQ Global Select Consolidated
國家United Kingdom
郵編WA14 2DT
電話17166766461
網址https://compasspathways.com/
公司代碼CMPS
上市日期Sep 18, 2020
CEOMr. Kabir Nath
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Robert McQuade, Ph.D.
Dr. Robert McQuade, Ph.D.
Independent Director
Independent Director
1.59M
--
Mr. Thomas Lonngren
Mr. Thomas Lonngren
Independent Director
Independent Director
89.05K
--
Mr. Kabir Nath
Mr. Kabir Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
29.07K
+944.11%
Mr. David Norton
Mr. David Norton
Independent Director
Independent Director
20.36K
+17.06%
Dr. Annalisa M. Jenkins
Dr. Annalisa M. Jenkins
Independent Director
Independent Director
19.48K
+17.97%
Ms. Teri Loxam
Ms. Teri Loxam
Chief Financial Officer
Chief Financial Officer
11.21K
-86.53%
Dr. Guy Goodwin
Dr. Guy Goodwin
Chief Medical Officer
Chief Medical Officer
1.99K
--
Mr. Justin Gover
Mr. Justin Gover
Director
Director
--
--
Dr. Linda Mcgoldrick, Ph.D.
Dr. Linda Mcgoldrick, Ph.D.
Independent Director
Independent Director
--
--
Ms. Daphne Karydas
Ms. Daphne Karydas
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Robert McQuade, Ph.D.
Dr. Robert McQuade, Ph.D.
Independent Director
Independent Director
1.59M
--
Mr. Thomas Lonngren
Mr. Thomas Lonngren
Independent Director
Independent Director
89.05K
--
Mr. Kabir Nath
Mr. Kabir Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
29.07K
+944.11%
Mr. David Norton
Mr. David Norton
Independent Director
Independent Director
20.36K
+17.06%
Dr. Annalisa M. Jenkins
Dr. Annalisa M. Jenkins
Independent Director
Independent Director
19.48K
+17.97%
Ms. Teri Loxam
Ms. Teri Loxam
Chief Financial Officer
Chief Financial Officer
11.21K
-86.53%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月16日 週五
更新時間: 5月16日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Deep Track Capital LP
9.23%
Atai Life Sciences AG
7.20%
RTW Investments L.P.
5.77%
TCG Crossover Management, LLC
4.02%
Vivo Capital, LLC
3.50%
Other
70.27%
持股股東
持股股東
佔比
Deep Track Capital LP
9.23%
Atai Life Sciences AG
7.20%
RTW Investments L.P.
5.77%
TCG Crossover Management, LLC
4.02%
Vivo Capital, LLC
3.50%
Other
70.27%
股東類型
持股股東
佔比
Hedge Fund
26.98%
Investment Advisor
11.34%
Investment Advisor/Hedge Fund
10.33%
Corporation
7.38%
Individual Investor
6.26%
Venture Capital
6.06%
Research Firm
1.05%
Endowment Fund
0.23%
Bank and Trust
0.05%
Other
30.32%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
277
64.91M
69.37%
+3.93M
2025Q1
287
65.16M
70.41%
+4.19M
2024Q4
278
44.23M
47.77%
-10.96M
2024Q3
271
50.07M
70.05%
-2.63M
2024Q2
274
48.30M
70.14%
-3.09M
2024Q1
276
47.45M
68.96%
+541.76K
2023Q4
283
43.21M
76.55%
-1.53M
2023Q3
283
43.38M
82.47%
+3.50M
2023Q2
280
29.35M
64.55%
-6.45M
2023Q1
287
29.33M
69.18%
+3.80M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Deep Track Capital LP
8.86M
9.47%
--
--
Mar 31, 2025
Atai Life Sciences AG
6.91M
7.38%
--
--
Mar 05, 2025
RTW Investments L.P.
5.54M
5.92%
+2.44M
+78.71%
Mar 31, 2025
TCG Crossover Management, LLC
3.86M
4.12%
--
--
Mar 31, 2025
Vivo Capital, LLC
3.36M
3.59%
+1.75M
+109.10%
Mar 31, 2025
Nantahala Capital Management, LLC
2.83M
3.02%
+1.83M
+182.92%
Mar 31, 2025
Millennium Management LLC
2.77M
2.96%
-639.93K
-18.75%
Mar 31, 2025
Goldsmith (George Jay)
2.05M
2.19%
-129.33K
-5.93%
Mar 31, 2025
Malievskaia (Ekaterina)
2.03M
2.17%
-149.38K
-6.86%
Mar 31, 2025
Logos Global Management LP
2.00M
2.14%
+2.00M
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
AdvisorShares Psychedelics ETF
7.05%
Virtus LifeSci Biotech Clinical Trials ETF
0.56%
ARK Genomic Revolution ETF
0.44%
ALPS Medical Breakthroughs ETF
0.18%
Invesco Nasdaq Biotechnology ETF
0.03%
ProShares Ultra Nasdaq Biotechnology
0.03%
iShares Biotechnology ETF
0.02%
SPDR S&P International Small Cap ETF
0.01%
Putnam Sustainable Future ETF
0%
Blueprint Chesapeake Multi-Asset Trend ETF
0%
查看更多
AdvisorShares Psychedelics ETF
佔比7.05%
Virtus LifeSci Biotech Clinical Trials ETF
佔比0.56%
ARK Genomic Revolution ETF
佔比0.44%
ALPS Medical Breakthroughs ETF
佔比0.18%
Invesco Nasdaq Biotechnology ETF
佔比0.03%
ProShares Ultra Nasdaq Biotechnology
佔比0.03%
iShares Biotechnology ETF
佔比0.02%
SPDR S&P International Small Cap ETF
佔比0.01%
Putnam Sustainable Future ETF
佔比0%
Blueprint Chesapeake Multi-Asset Trend ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
